• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    February 18, 2022 - FDA Alerts the Public to Potentially Contaminated Products from Family Dollar Stores in Six States

    2/18/22 8:06:10 PM ET
    $ARVL
    Auto Manufacturing
    Consumer Discretionary
    Get the next $ARVL alert in real time by email
    For Immediate Release:
    February 18, 2022

    Today, the U.S. Food and Drug Administration is alerting the public that several categories of FDA-regulated products purchased from Jan. 1, 2021, through the present from Family Dollar stores in Alabama, Arkansas, Louisiana, Mississippi, Missouri and Tennessee may be unsafe for consumers to use. The impacted products originated from the company’s distribution facility in West Memphis, Arkansas, where an FDA inspection found insanitary conditions, including a rodent infestation, that could cause many of the products to become contaminated. The FDA is working with the company to initiate a voluntary recall of the affected products.

    “Families rely on stores like Family Dollar for products such as food and medicine. They deserve products that are safe,” said Associate Commissioner for Regulatory Affairs Judith McMeekin, Pharm.D. “No one should be subjected to products stored in the kind of unacceptable conditions that we found in this Family Dollar distribution facility. These conditions appear to be violations of federal law that could put families’ health at risk. We will continue to work to protect consumers.”

    This alert covers FDA-regulated products purchased from Family Dollar stores in those six states from Jan. 1, 2021, through the present. Some examples of these products include human foods (including dietary supplements (vitamin, herbal and mineral supplements)), cosmetics (skincare products, baby oils, lipsticks, shampoos, baby wipes), animal foods (kibble, pet treats, wild bird seed), medical devices (feminine hygiene products, surgical masks, contact lens cleaning solutions, bandages, nasal care products) and over-the-counter (OTC) medications (pain medications, eye drops, dental products, antacids, other medications for both adults and children). 

    Consumers are advised not to use and to contact the company regarding impacted products. The agency is also advising that all drugs, medical devices, cosmetics and dietary supplements, regardless of packaging, be discarded. Food in non-permeable packaging (such as undamaged glass or all-metal cans) may be suitable for use if thoroughly cleaned and sanitized. Consumers should wash their hands immediately after handling any products from the affected Family Dollar stores.

    Consumers who recently purchased affected products should contact a health care professional immediately if they have health concerns after using or handling impacted products. Rodent contamination may cause Salmonella and infectious diseases, which may pose the greatest risk to infants, children, pregnant women, the elderly and immunocompromised people.

    Following a consumer complaint, the FDA began an investigation of the Family Dollar distribution facility in West Memphis, Arkansas, in January 2022. Family Dollar ceased distribution of products within days of the FDA inspection team’s arrival on-site and the inspection concluded on Feb. 11. Conditions observed during the inspection included live rodents, dead rodents in various states of decay, rodent feces and urine, evidence of gnawing, nesting and rodent odors throughout the facility, dead birds and bird droppings, and products stored in conditions that did not protect against contamination. More than 1,100 dead rodents were recovered from the facility following a fumigation at the facility in January 2022. Additionally, a review of the company’s internal records also indicated the collection of more than 2,300 rodents between Mar. 29 and Sep. 17, 2021, demonstrating a history of infestation.

    Related Information

    Related Information
    • Recalls, Market Withdrawals & Safety Alerts
    • Report a Problem to the FDA

    ###

    Boilerplate

    The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.


    Inquiries

    Media:
    Audra Harrison
    301-908-6101
    Consumer:
    888-INFO-FDA

    Get the next $ARVL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ARVL

    DatePrice TargetRatingAnalyst
    3/10/2022$20.00 → $6.00Overweight
    Barclays
    10/6/2021$17.00Buy
    Berenberg
    More analyst ratings

    $ARVL
    SEC Filings

    See more
    • SEC Form 6-K filed by Arrival

      6-K - Arrival (0001835059) (Filer)

      2/5/24 12:46:50 PM ET
      $ARVL
      Auto Manufacturing
      Consumer Discretionary
    • SEC Form 6-K filed by Arrival

      6-K - Arrival (0001835059) (Filer)

      1/29/24 8:30:12 AM ET
      $ARVL
      Auto Manufacturing
      Consumer Discretionary
    • SEC Form 6-K filed by Arrival

      6-K - Arrival (0001835059) (Filer)

      1/10/24 4:12:01 PM ET
      $ARVL
      Auto Manufacturing
      Consumer Discretionary

    $ARVL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • ARRIVAL to Report Second Quarter 2023 Business Updates in Early September 2023

      LUXEMBOURG, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Arrival (NASDAQ:ARVL) ("Arrival" or the "Company"), inventor of a unique new method of design and production of electric vehicles, today announced that it intends to hold a business update for the second quarter of 2023 in early September 2023. The Company will announce the exact date and time of the update at which it will host a corresponding webinar in due course. The live webinar will be accessible on the Company's website at investors.arrival.com. About ArrivalArrival's mission is to master a radically more efficient New Method to design, produce, sell and service purpose-built electric vehicles, to support a world where cities are free

      8/14/23 8:30:00 AM ET
      $ARVL
      Auto Manufacturing
      Consumer Discretionary
    • Arrival and Kensington Capital Acquisition Corp. V Agreed to Terminate Business Combination Agreement

      Kensington Capital Acquisition Corp V (NYSE:KCGI) and Arrival (NASDAQ:ARVL) have agreed to terminate the business combination agreement signed April 6, 2023Following the termination of the agreement, Arrival intends to pursue alternative fundraising opportunities.Arrival has engaged TD Cowen to assist in developing other strategic opportunities. LUXEMBOURG and WESTBURY, N.Y., July 03, 2023 (GLOBE NEWSWIRE) -- Arrival (NASDAQ:ARVL) ("Arrival" or the "Company"), inventor of a unique new method of design and production of electric vehicles ("EVs"), and Kensington Capital Acquisition Corp. V ("Kensington") (NYSE:KCGI), a special purpose acquisition company, today announced that both companies

      7/3/23 4:30:00 PM ET
      $ARVL
      $KCGI
      Auto Manufacturing
      Consumer Discretionary
      Blank Checks
      Finance
    • ARRIVAL To Exchange $20M Debt for Equity with Antara

      LUXEMBOURG, June 06, 2023 (GLOBE NEWSWIRE) -- Arrival (NASDAQ:ARVL, the "Company"))), inventor of a unique new method of design and production of electric vehicles, today announced that it has agreed to amend the debt-to-equity transaction agreement with Antara Capital Master Fund LP ("Antara"), resulting in its exchange of $20 million principal amount of 3.50% convertible notes due 2026 ("Notes") for 3,024,194 ordinary shares ("Ordinary Shares"). In connection with the exchange, Antara has agreed that it will not sell or otherwise dispose of the Ordinary Shares that it receives in the exchange in an amount greater than 10% of the traded volume of the Company's Ordinary Shares on any given

      6/6/23 7:20:36 AM ET
      $ARVL
      Auto Manufacturing
      Consumer Discretionary